Harvard Bioscience Inc Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 0.09M19.02M-1.48M-2.12M-2.55M2.35M-19.04M-4.34M1.15M1.38M-4.80M-7.95M-0.66M-10.01M-3.42M-12.40M
Depreciation and Depletion 1.20M1.20M1.28M1.27M1.30M1.25M1.75M1.53M1.32M2.42M1.99M1.92M1.78M1.45M1.50M1.73M
Share-based Compensation 2.51M2.76M2.86M3.32M2.67M2.16M2.75M3.50M3.50M3.04M3.03M3.65M4.17M4.41M5.00M4.34M
Deferred Taxes 0.47M-11.73M-0.85M-0.73M-2.44M1.41M15.12M-0.28M-1.58M-2.86M
Gains from Sales and Divestitures 0.81M0.81M0.93M1.17M0.73M1.14M0.72M
Gains from Investment Securities 1.92M1.78M0.01M2.27M2.27M2.64M1.40M1.24M0.92M0.83M
Asset Writedowns and Impairment -0.01M-0.15M0.07M-0.03M0.17M-0.07M-0.01M0.68M-0.11M0.03M1.50M0.79M
Cash from Restructuring 0.23M0.08M0.21M-0.01M-0.05M-0.12M-0.09M-0.03M
Non-cash Items 0.26M2.49M5.55M0.19M1.84M
Change in Working Capital 2.22M0.06M
Change in Receivables -3.23M1.09M-0.23M-1.15M1.02M0.73M1.34M0.66M-0.20M2.79M-0.47M-3.10M4.29M-4.78M-0.81M-0.97M
Change in Inventory 0.04M1.24M1.71M-1.17M-1.92M3.06M1.22M-1.25M0.55M-2.55M-3.26M-0.41M5.86M-0.25M-1.52M0.06M
Change in Account Payables -1.02M0.06M0.07M-0.91M-0.04M1.07M2.58M-2.41M-0.92M1.59M-2.05M0.51M
Change in Accured Expenses 2.22M0.39M-1.37M-0.48M0.85M-0.84M-1.79M0.87M-2.01M-3.15M-1.92M1.49M-2.56M-1.40M-0.52M-1.78M
Change in Taxes -0.34M0.44M-0.54M0.21M0.32M-0.27M-0.31M-0.20M0.21M0.61M-0.36M
Other Working Capital Changes -0.16M0.02M0.03M-0.05M0.15M0.03M0.12M-0.19M0.10M-2.86M-0.17M-0.29M0.51M-0.90M-1.65M-1.64M
Cash from Operations 16.51M12.29M6.65M8.06M4.06M4.35M0.70M5.38M1.06M2.88M8.04M9.33M1.26M1.15M14.03M1.44M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 1.84M2.36M2.75M2.75M2.59M2.58M2.82M2.72M2.44M5.43M5.75M5.71M5.84M6.12M5.53M5.43M
Amortization of Deferred Charges 0.06M0.09M0.09M0.05M0.05M0.06M0.09M0.09M0.04M0.65M0.39M0.39M0.28M0.28M0.28M0.33M
Depreciation & Amortization (CF) 1.20M3.92M4.33M4.21M1.30M1.25M1.75M1.53M1.32M2.42M1.99M1.92M1.78M1.45M1.50M1.73M
Investing Activities
Capital Expenditures -1.38M-0.84M-1.51M-1.77M-1.62M-2.00M-2.96M-1.45M0.89M0.99M1.22M1.15M1.20M1.59M1.79M2.64M
Sales of Property, Plant and Equipment 0.00M0.03M0.03M0.03M0.07M1.14M0.01M0.01M0.00M
Change in Intangibles 0.25M0.15M0.52M0.62M
Acquisitions 20.76M7.12M5.46M2.88M12.65M4.54M68.55M
Divestments 1.78M1.42M15.75M1.00M0.51M
Change in Acquisitions & Divestments 1.92M
Cash from Investing Activities -22.30M-8.35M-7.20M-4.68M0.17M-13.52M-7.52M-0.06M-0.92M-53.80M-0.23M-1.40M-1.34M-1.59M-1.80M-1.34M
Financing Activities
Other financing activities -0.29M0.31M0.03M2.01M0.56M1.30M3.51M1.63M2.52M0.58M
Cash from Financing Activities 9.79M-0.03M-1.14M-1.06M0.07M-1.23M-0.54M-4.87M-1.79M53.05M-7.62M-7.97M-0.25M-2.84M-12.13M-0.13M
Additional items
Exchange Rate Effect -1.10M-0.80M-0.10M0.44M0.79M-1.24M-0.04M-1.60M1.79M0.30M-0.03M0.02M-0.16M-0.04M-0.32M-0.14M
Change in Cash 2.89M3.12M-1.79M2.77M5.09M-11.64M-7.39M-1.15M0.14M2.44M0.16M-0.02M-0.50M-3.31M-0.23M-0.17M
Beginning Cash Balance 13.70M16.59M19.70M17.92M20.68M25.77M14.13M6.74M5.60M5.73M8.17M8.34M8.32M7.82M4.51M4.28M
Free Cash Flow 17.89M13.14M8.15M9.83M5.68M6.36M3.67M6.83M0.17M1.90M6.83M8.18M0.07M-0.44M12.24M-1.20M
Net Cash Flow 3.99M3.92M-1.69M2.32M4.30M-10.40M-7.35M0.45M-1.65M2.14M0.19M-0.04M-0.34M-3.27M0.10M-0.04M